Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Montse Guardiola und 13 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Medicina i Cirurgia, Unitat de Recerca en Lípids i Arteriosclerosi (URLA), Universitat Rovira i Virgili, Reus, Spain. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Lipoproteins, Cardiovascular Diseases, Heart Disease Risk Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Regional Development Fund, Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas, Ministerio de Economía y Competitividad.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The burden of cardiovascular disease is particularly high among individuals with diabetes, even when LDL cholesterol is normal or within the therapeutic target. Despite this, cholesterol accumulates in their arteries, in part, due to persistent atherogenic dyslipidaemia characterized by elevated triglycerides, remnant cholesterol, smaller LDL particles and reduced HDL cholesterol. The causal link between dyslipidaemia and atherosclerosis in T2DM is complex, and our contention is that a deeper understanding of lipoprotein composition and functionality, the vehicle that delivers cholesterol to the artery, will provide insight for improving our understanding of the hidden cardiovascular risk of diabetes. This narrative review covers three levels of complexity in lipoprotein characterization: 1—the information provided by routine clinical biochemistry, 2—advanced nuclear magnetic resonance (NMR)‐based lipoprotein profiling and 3—the identification of minor components or physical properties of lipoproteins that can help explain arterial accumulation in individuals with normal LDLc levels, which is typically the case in individuals with T2DM. This document highlights the importance of incorporating these three layers of lipoprotein‐related information into population‐based studies on ASCVD in T2DM. Such an attempt should inevitably run in parallel with biotechnological solutions that allow large‐scale determination of these sets of methodologically diverse parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departament de Medicina i Cirurgia, Unitat de Recerca en Lípids i Arteriosclerosi (URLA), Universitat Rovira i Virgili, Reus, Spain.
- Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
- Departament de Ciències Mèdiques Bàsiques, Universitat Rovira i Virgili, Reus, Spain.
- Biosfer Teslab, Reus, Spain.
- Department of Endocrinology, Hospital Ramón y Cajal, Madrid, Spain.
ORCID-Profile: Emilio Ortega, Josep Ribalta
Förderung
- European Regional Development Fund
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
- Ministerio de Economía y Competitividad
- Ministerio de Universidades
- Generalitat de Catalunya
Zitieren
APA
Guardiola, M., Rehues, P., Amigó, N., Arrieta, F., Botana, M., Gimeno-Orna, J. A., Girona, J., Martínez-Montoro, J. I., Ortega, E., Pérez-Pérez, A., Sánchez-Margalet, V., Pedro-Botet, J., Ribalta, J., & Cardiovascular Disease Group of the Spanish Society of Diabetes (2024). Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14214
Vancouver
Guardiola M, Rehues P, Amigó N, Arrieta F, Botana M, Gimeno-Orna JA, et al. Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14214
BibTeX
@article{Guardiola2024,
author = {Guardiola, Montse and Rehues, Pere and Amigó, Núria and Arrieta, Francisco and Botana, Manuel and Gimeno-Orna, José A and Girona, Josefa and Martínez-Montoro, José Ignacio and Ortega, Emilio and Pérez-Pérez, Antonio and Sánchez-Margalet, Víctor and Pedro-Botet, Juan and Ribalta, Josep and Cardiovascular Disease Group of the Spanish Society of Diabetes, Cardiovascular Disease Group of the Spanish Society of Diabetes},
title = {Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14214}
}
EUVIMED